Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Hawkins

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Journal of Clinical Epidemiology|June 26, 2012
Investigating incoherence gives insight: clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke preventionSarah Dewilde, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 19, 2021
Evaluation of Triage Tests When Existing Test Capacity Is Constrained: Application to Rapid Diagnostic Testing in COVID-19Janet Bouttell, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 31, 2017
Extrapolation of Survival Data in Cost-effectiveness Analyses: The Need for Causal ClarityNeil Hawkins, Richard Grieve
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 16, 2010
Cost-effectiveness analysis: discount the placebo at your perilNeil Hawkins, David A Scott
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 22, 2009
Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitisYogesh Suresh Punekar, Neil Hawkins
Health Economics|June 23, 2010
Reimbursement and value-based pricing: stratified cost-effectiveness analysis may not be the last wordNeil Hawkins, David A Scott
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2008
Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologiesMarco Barbieri, Neil Hawkins, Mark Sculpher
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatmentBeth Woods, David Veenstra, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 15, 2005
Cost-effectiveness analysis of treatments for chronic disease: using R to incorporate time dependency of treatment responseNeil Hawkins, Mark Sculpher, David Epstein
Pharmacoeconomics - Open|July 2, 2025
Missing Pieces of the Puzzle to Address Market Failures for Antibiotics: Delinked Payment Systems and Insurance ValueNeil Hawkins, Adrian Towse, Amanda Adler
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Journal of Clinical Epidemiology|June 26, 2012
Investigating incoherence gives insight: clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke preventionSarah Dewilde, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 19, 2021
Evaluation of Triage Tests When Existing Test Capacity Is Constrained: Application to Rapid Diagnostic Testing in COVID-19Janet Bouttell, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 31, 2017
Extrapolation of Survival Data in Cost-effectiveness Analyses: The Need for Causal ClarityNeil Hawkins, Richard Grieve
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 16, 2010
Cost-effectiveness analysis: discount the placebo at your perilNeil Hawkins, David A Scott
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 22, 2009
Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitisYogesh Suresh Punekar, Neil Hawkins
Health Economics|June 23, 2010
Reimbursement and value-based pricing: stratified cost-effectiveness analysis may not be the last wordNeil Hawkins, David A Scott
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2008
Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologiesMarco Barbieri, Neil Hawkins, Mark Sculpher
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatmentBeth Woods, David Veenstra, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 15, 2005
Cost-effectiveness analysis of treatments for chronic disease: using R to incorporate time dependency of treatment responseNeil Hawkins, Mark Sculpher, David Epstein
Pharmacoeconomics - Open|July 2, 2025
Missing Pieces of the Puzzle to Address Market Failures for Antibiotics: Delinked Payment Systems and Insurance ValueNeil Hawkins, Adrian Towse, Amanda Adler
Pageof 11